Restricted accessResearch articleFirst published online 2015-09
Solanum tuberosum L. cv Jayoung Epidermis Extract Inhibits Mite Antigen-Induced Atopic Dermatitis in NC/Nga Mice by Regulating the Th1/Th2 Balance and Expression of Filaggrin
Solanum tuberosum L. cv Jayoung (JY) is a potato with dark purple flesh and contains substantial amounts of polyphenols. In this study, we evaluated the therapeutic effects of S. tuberosum L. cv JY in a mouse model of Dermatophagoides farinae body (Dfb)-induced atopic dermatitis (AD). The ethanol extract of the peel of JY (EPJ) ameliorated Dfb-induced dermatitis severity, serum levels of immunoglobulin E (IgE) and thymus and activation-regulated chemokine. Histological analysis of the skin also revealed that EPJ treatment significantly decreased mast cell infiltration. The suppression of dermatitis by EPJ treatment was accompanied by a decrease in the skin levels of type 2 helper T-cell cytokines such as interleukin (IL)-4, IL-5, and IL-13. The induction of thymic stromal lymphopoietin, which leads to a systemic Th2 response, was also decreased in the skin by EPJ. Nuclear translocation of nuclear factor-κB p65 was decreased by EPJ in Dfb-induced NC/Nga mice. The protein expression of filaggrin in the AD-like skin lesions was restored by EPJ treatment. These results suggested that EPJ may be a potential therapeutic tool for the treatment of AD.
Get full access to this article
View all access options for this article.
References
1.
SimpsonEL, HanifinJM: Atopic dermatitis. Med Clin North Am, 2006; 90:149–167, ix.
2.
RomagnaniS: Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol, 2004; 113:395–400.
3.
NovakN, BieberT: The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol, 2005; 53:S171–S176.
4.
BieberT: Atopic dermatitis. N Engl J Med, 2008; 358:1483–1494.
5.
LeungDY, BoguniewiczM, HowellMD, et al.: New insights into atopic dermatitis. J Clin Invest, 2004; 113:651–657.
6.
BreuerK, WerfelT, KappA: Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol, 2005; 6:65–77.
7.
HultschT, KappA, SpergelJ: Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology, 2005; 211:174–187.
8.
NiwaY, TerashimaT, SumiH: Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol, 2003; 149:960–967.
9.
OjewoleJA: Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm [“African Potato”] aqueous extract in mice and rats. J Ethnopharmacol, 2006; 103:126–134.
10.
EspositoD, ChenA, GraceMH, et al.: Inhibitory effects of wild blueberry anthocyanins and other flavonoids on biomarkers of acute and chronic inflammation in vitro. J Agric Food Chem, 2014; 62:7022–7028.
11.
LeeSJ, ShinJS, ChoiHE, et al.: Chloroform fraction of Solanum tuberosum L. cv Jayoung epidermis suppresses LPS-induced inflammatory responses in macrophages and DSS-induced colitis in mice. Food Chem Toxicol, 2014; 63:53–61.
12.
ParkYE, ChoHM, HwangYS, et al.: Antimutagenic effect and cytotoxicity to human cancer cell lines of colored potato extracts. Korean J Crop Sci, 2008; 53:75–84.
13.
NamJH, JeongJC, KwonOK, et al.: Anti-inflammatory activity of peel extracts in color-fleshed potatoes. Korean J Plant Res, 2013; 26:533–538.
14.
SoneK, Yamamoto-SawamuraT, KuwaharaS, et al.: Changes of estrous cycles with aging in female F344/n rats. Exp Anim, 2007; 56:139–148.
15.
KodaA, InagakiN, TsuruokaN, et al.: Specific suppression of antigen-antibody reactions by a dialysate from Dermatophagoides farinae. J Pharmacobiodyn, 1987; 10:104–111.
16.
AminK: The role of mast cells in allergic inflammation. Respir Med, 2012; 106:9–14.
17.
WesolowskiJ, PaumetF: The impact of bacterial infection on mast cell degranulation. Immunol Res, 2011; 51:215–226.
18.
GaoXK, NakamuraN, FusedaK, et al.: Establishment of allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis. Biol Pharm Bull, 2004; 27:1376–1381.
19.
KouK, AiharaM, MatsunagaT, et al.: Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis. Arch Dermatol Res, 2012; 304:305–312.
LiuYJ: Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol, 2007; 120:238–244; quiz 245–236.
22.
KishimotoT, HiranoT: Molecular regulation of B lymphocyte response. Annu Rev Immunol, 1988; 6:485–512.
23.
NakamuraH, AokiM, TamaiK, et al.: Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther, 2002; 9:1221–1229.
24.
LeeHC, HeadleyMB, IsekiM, et al.: Cutting edge: Inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor. J Immunol, 2008; 181:5189–5193.
GelbardCM, HebertAA: New and emerging trends in the treatment of atopic dermatitis. Patient Prefer Adherence, 2008; 2:387–392.
27.
MatsuokaH, MakiN, YoshidaS, et al.: A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy, 2003; 58:139–145.
28.
ShimadaY, TakeharaK, SatoS: Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci, 2004; 34:201–208.
29.
WerfelT: The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol, 2009; 129:1878–1891.
30.
OyoshiMK, HeR, KumarL, et al.: Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol, 2009; 102:135–226.
31.
NovakN: An update on the role of human dendritic cells in patients with atopic dermatitis. J Allergy Clin Immunol, 2012; 129:879–886.
YuanXY, MaHM, LiRZ, et al.: Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. Eur J Pharmacol, 2011; 658:263–269.
34.
OzawaT, KoyamaK, AndoT, et al.: Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-kappaB pathway and interferon-gamma/dexamethasone. Mod Rheumatol, 2007; 17:459–463.
35.
KimSJ, KimJS, ChoiIY, et al.: Anti-inflammatory activity of Schizonepeta tenuifolia through the inhibition of MAPK phosphorylation in mouse peritoneal macrophages. Am J Chin Med, 2008; 36:1145–1158.
36.
SmahiA, CourtoisG, RabiaSH, et al.: The NF-κB signalling pathway in human diseases: From incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet, 2002; 11:2371–2375.
37.
MaW, BrycePJ, HumblesAA, et al.: CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest, 2002; 109:621–628.
38.
CandiE, SchmidtR, MelinoG: The cornified envelope: A model of cell death in the skin. Nat Rev Mol Cell Biol, 2005; 6:328–340.
39.
GalvinS, LoomisC, ManabeM, et al.: The major pathways of keratinocyte differentiation as defined by keratin expression: An overview. Adv Dermatol, 1989; 4:277–299; discussion 300.
40.
JangSI, SteinertPM, MarkovaNG: Activator protein 1 activity is involved in the regulation of the cell type-specific expression from the proximal promoter of the human profilaggrin gene. J Biol Chem, 1996; 271:24105–24114.
SandilandsA, SutherlandC, IrvineAD, et al.: Filaggrin in the frontline: Role in skin barrier function and disease. J Cell Sci, 2009; 122:1285–1294.
43.
JuHK, LeeHW, ChungKS, et al.: Standardized flavonoid-rich fraction of Artemisia princeps Pampanini cv. Sajabal induces apoptosis via mitochondrial pathway in human cervical cancer HeLa cells. J Ethnopharmacol, 2012; 141:460–468.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
